You just read:

Pan Am Cancer Treatment Center Provides Final HemaXellerate Clinical Data to Regen BioPharma, Inc. for treatment of Bone Marrow Suppression Study

News provided by

Regen BioPharma, Inc.

24 Oct, 2016, 08:00 ET